Letter

Poor response to erythropoietin

BMJ 1995; 311 doi: 10.1136/bmj.311.7005.633a (Published 2 September 1995)
Cite this as: BMJ 1995;311:633.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Judith Strachan,
  2. Laura Fleming,
  3. John Dick,
  4. Iain Henderson,
  5. Callum Fraser,
  6. Michael Jones,
  7. Ellon McGregor
  1. Senior biochemist Research fellow Senior registrar Consultant Top grade scientist, biochemical medicine Consultant Consultant, renal medicine Ninewells Hospital and Medical School, Dundee Teaching Hospitals NHS Trust, Dundee DD1 9SY

    EDITOR,--Iain C MacDougall's editorial on poor response to treatment with erythropoietin outlines a rational approach to this problem.1 We agree with his scheme of how to investigate and manage patients who apparently show resistance to erythropoietin but would strongly advocate one further investigation--namely, assay of plasma erythropoietin concentrations in such patients. …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular